|
|
???tair.name??? >
???browser.page.title.author???
|
"tseng kuo chih"???jsp.browse.items-by-author.description???
Showing items 11-35 of 49 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-01-18T09:12:03Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
CHEN-HUA LIU; Chen, Chi Yi; Su, Wei Wen; Tseng, Kuo Chih; Lo, Ching Chu; CHUN-JEN LIU; Chen, Jyh Jou; Peng, Cheng Yuan; Shih, Yu Lueng; Yang, Sheng Shun; Huang, Chia Sheng; Huang, Ke Jhang; Chang, Chi Yang; Tsai, Ming Chang; Kao, Wei Yu; Fang, Yo Jen; Chen, Po Yueh; Su, Pei Yuan; Tseng, Chih Wei; Huang, Jow Jyh; Lee, Pei Lun; Lai, Hsueh Chou; Hsieh, Tsai Yuan; Chang, Chung Hsin; Huang, Yi Jie; Lee, Fu Jen; Chang, Chun Chao; Kao, Jia-Horng |
| 臺大學術典藏 |
2019-10-23T13:07:22Z |
Limited drug–drug interaction of elbasvir/grazoprevir for chronic hepatitis C
|
CHUN-JEN LIU;Tseng, I. Hao;Tseng, Kuo Chih;Lo, Ching Chu;Cheng, Pin Nan; Cheng, Pin Nan; Lo, Ching Chu; Tseng, Kuo Chih; CHUN-JEN LIU; Tseng, I. Hao |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg
|
Wang, Chia-Chi;Tseng, Kuo-Chih;Hsieh, Tsai-Yuan;Tseng, Tai-Chung;Lin, Hans Hsienhong;Kao, Jia-Horng; Wang, Chia-Chi; JIA-HORNG KAO; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Tseng, Tai-Chung; Lin, Hans Hsienhong; Kao, Jia-Horng |
| 淡江大學 |
2016-11-01 |
No Difference in Mortality between Terlipressin and Somatostatin Treatments in Cirrhotic Patients with Esophageal Variceal Bleeding and Renal Functional Impairment
|
Hung, Tsung-Hsing;Tsai, Chen-Chi;Tseng, Chih-Wei;Tseng, Kuo-Chih;Hsieh, Yu-Hsi;Tsai, Chih-Chun |
| 淡江大學 |
2016-09-15 |
The Effect of the First Spontaneous Bacterial Peritonitis Event on the Mortality of Cirrhotic Patients with Ascites: A Nationwide Population-Based Study in Taiwan
|
Hung, Tsung-Hsing;Tsai, Chen-Chi;Hsieh, Yu-Hsi;Tsai, Chih-Chun;Tseng, Chih-Wei;Tseng, Kuo-Chih |
| 淡江大學 |
2016-03-11 |
High Mortality of Cirrhotic Patients with End-Stage Renal Disease
|
Hung, Tsung-Hsing;Tsai, Chen-Chi;Tseng, Kuo-Chih;Tseng, Chih -Wei;Hsieh, Yu-Hsi;Tsai, Chih-Chun;Lee, Hsing-Feng |
| 國立成功大學 |
2016 |
Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin
|
Ng, Khai-Jing;Tseng, Chih-Wei;Chang, Ting-Tsung;Tzeng, Shinn-Jia;Hsieh, Yu-Hsi;Hung, Tsung-Hsing;Huang, Hsiang-Ting;Wu, Shu-Fen;Tseng, Kuo-Chih |
| 國立成功大學 |
2016 |
Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
|
Tseng, Chih-Wei;Chang, Ting-Tsung;Tzeng, Shinn-Jia;Hsieh, Yu-Hsi;Hung, Tsung-Hsing;Huang, Hsiang-Ting;Wu, Shu-Fen;Tseng, Kuo-Chih |
| 國立臺灣大學 |
2016 |
Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues
|
Tseng, Kuo-Chih; Tseng, Chih-Wei; Hsieh, Tsai-Yuan; Peng, Cheng-Yuan; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg
|
Wang, Chia-Chi; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Tseng, Tai-Chung; Lin, Hans Hsienhong; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
|
Wang, Chia-Chi; Lin, Chih-Lin; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Peng, Cheng-Yuan; Su, Tung-Hung; Yang, Sheng-Shun; Hsu, Yu-Chun; Chen, Tsung-Ming; Kao, Jia-Horng; 高嘉宏; 蘇東弘 |
| 國立臺灣大學 |
2016 |
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Bair, Ming-Jong; Liang, Cheng-Chao; Lei, Yung-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立成功大學 |
2015-09-14 |
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
|
Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung |
| 國立成功大學 |
2015-02 |
Effect of liver cirrhosis on metastasis in colorectal cancer patients: a nationwide population-based cohort study
|
Chiou, Wen-Yen; Chang, Chun-Ming; Tseng, Kuo-Chih; Hung, Shih-Kai; Lin, Hon-Yi; Chen, Yi-Chun; Su, Yu-Chieh; Tseng, Chih-Wei; Tsai, Shiang-Jiun; Lee, Moon-Sing; Li, Chung-Yi |
| 國立臺灣大學 |
2015 |
平衡計分卡在肝癌的應用: 以南部一區域教學醫院為例
|
曾國枝; Tseng, Kuo-Chih |
| 國立臺灣大學 |
2015 |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng, Cheng-Yuan; Hsieh, Tsung-Cheng; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
|
Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung; 徐士哲; 劉俊人 |
| 國立臺灣大學 |
2015 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立成功大學 |
2014-11 |
Safety and rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Asian treatment experienced HCV-1 patients
|
Yu, Ming Lung; Yang, Chi Chieh; Wei-Lun, Tsai; Su, Wei Wen; Cheng, Pin Nan; Lo, Ching Chu; Tseng, Kuo Chih; Mo, Lein Ray; Chun-Hsiang, Wang; Hsu, Shih Jer; Lai, Hsueh Chou; Su, Chien Wei; Liu, Chun Jen |
| 淡江大學 |
2014-09 |
Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients With Hepatic Encephalopathy: A Population-Based 3-Year Follow-Up Study
|
Hung, Tsung-Hsing; Tseng, Chih-Wei; Tseng, Kuo-Chih; Hsieh, Yu-Hsi; Tsai, Chih-Chun; Tsai, Chen-Chi |
| 國立成功大學 |
2014-06-17 |
Peginterferon Alfa-2a Is Associated with Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients with Sustained Virologic Response
|
Tseng, Chih-Wei; Chen, Chi-Yi; Chang, Ting-Tsung; Tzeng, Shinn-Jia; Hsieh, Yu-Hsi; Hung, Tsung-Hsing; Lee, Ching-Chih; Wu, Shu-Fen; Tseng, Kuo-Chih |
| 臺北醫學大學 |
2014 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study
|
Su, Tung-Hung;Hu, Tsung-Hui;Chen, Chi-Yi;Huang, Yi-Hsiang;Chuang, Wan-Long;Lin, Chun-Che;Wang, Chia-Chi;Su, Wei-Wen;Peng, Cheng-Yuan;Chien, Rong-Nan;Mo, Lein-Ray;Huang, Yi-Wen;Chen, Ming-Yao;Lin, Chih-Lin;Chen, Tsung-Ming;Wang, Horng-Yuan;Tseng, Kuo-Chih;Yang, Sheng-Shun;Hsu, Shih-Jer;Suk, Fat-Moon;Hu, Chi-Tan;Hsieh, Tsai-Yuan;Ming-jong, Bair;Liang, Cheng-Chao;Tseng, Tai-Chung;Chen, Chi-Ling;Kao, Jia-Horng |
| 國立成功大學 |
2014 |
Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study
|
Tseng, Kuo-Chih; Chen, Chi-Yi; Tsai, Hung-Wen; Chang, Ting-Tsung; Chuang, Wan-Long; Hsu, Ping-I; Liu, Wen-Chun; Cheng, Pin-Nan |
| 國立臺灣大學 |
2014 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立成功大學 |
2013-08 |
Effect of human leukocyte antigen class I and II alleles on hepatitis C viral load among chronic hepatitis C patients in Southern Taiwan
|
Tseng, Kuo-Chih; Tseng, Chih-Wei; Hsieh, Yu-Hsi; Chang, Chin-Kuo; Lai, Ning-Sheng; Hung, Tsung-Hsing; Chang, Ting-Tsung |
Showing items 11-35 of 49 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
